Skip to main content
. 2021 Apr 11;9(4):806. doi: 10.3390/microorganisms9040806

Table 2.

Comparison of outcomes of patients in the convalescent plasma and the control group.

Convalescent Plasma Group (n = 59) Control Group (n = 59) p-Value 1
Status at day 14 n (%) n (%) 0.249
Discharged 21 (35.6) 31 (52.5)
Hospitalized 30 (50.8) 18 (30.5)
In ICU 8 (13.6) 5 (8.5)
Death 0 (0.0) 5 (8.5)
Status at day 28 n (%) n (%) 0.566
Discharged 48 (81.4) 46 (78.0)
Hospitalized 5 (8.5) 5 (8.5)
In ICU 5 (8.5) 3 (5.1)
Death 1 (1.7) 5 (8.5)
Status at end of follow-up n (%) n (%) 0.106
Discharged 56 (94.9 51 (86.4)
Hospitalized 0 (0.0) 0 (0.0)
In ICU 1 (1.7) 0 (0.0)
Death 2 (3.4) 8 (13.6)
Follow-up, median (IQR) 29 (24) 10 (11) <0.001
Duration of hospital stay, median (IQR) 15 (10) 10 (11) 0.006
Admission to ICU, n (%) 16 (27.1) 9 (15.3) 0.116
Exit from ICU, n (%) 13 (22.0) 2 (3.4) 0.014
Time to exit from ICU, median (IQR) 12.5 (37.25) 7 (NC) 0.824
Intubation, n (%) 16 (27.1) 8 (13.6) 0.068
Extubation, n (%) 13 (22.0) 1 (1.7) 0.006
Time to extubation, median (IQR) 15 (35.5) 17.5 (NC) 0.837
Duration of oxygen support, median (IQR) 7 (11.5) NA
Achievement of negative PCR, n (%) 37 (62.7) 19 (52.8) 0.167
Time to PCR negativity, median (IQR) 14 (14) 9.5 (14.8) 0.007

1 Highlighted (bold) p-values denote statistically significant results.